Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation
Authors
Keywords
Shikonin, Paclitaxel, Multidrug resistance, Reactive oxygen species, Pyruvate kinase M2, P-glycoprotein
Journal
Chinese Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-03-14
DOI
10.1186/s13020-019-0231-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide
- (2018) Bin Lu et al. CANCER LETTERS
- ABC transporters as cancer drivers: Potential functions in cancer development
- (2018) Alice Domenichini et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Overcoming transporter-mediated multidrug resistance in cancer: failures and achievements of the last decades
- (2018) Miglė Paškevičiūtė et al. Drug Delivery and Translational Research
- Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes
- (2017) Kenneth K.W. To et al. JOURNAL OF ETHNOPHARMACOLOGY
- Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells
- (2017) Liang Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- Curcumin re-sensitizes multidrug resistant (MDR) breast cancer to cisplatin through inducing autophagy by decreasing CCAT1 expression
- (2017) Lv Xiao-ai et al. RSC Advances
- Regulation of multidrug resistance by microRNAs in anti-cancer therapy
- (2017) Xin An et al. Acta Pharmaceutica Sinica B
- Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo
- (2016) Guodong He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of Psoralen as an Anti-tumor Agent in Human Breast Cancer MCF-7/ADR Cells
- (2016) Xiaohong Wang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Shikonin Induces Apoptotic Cell Death via Regulation of p53 and Nrf2 in AGS Human Stomach Carcinoma Cells
- (2016) Hyeonseok Ko et al. Biomolecules & Therapeutics
- Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb–drug interactions
- (2016) Xu Wu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression
- (2015) Shengpeng Wang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
- (2015) Jelena Dinic et al. CURRENT PHARMACEUTICAL DESIGN
- Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?
- (2014) Álvaro Henrique Ingles Garces et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Shikonin time-dependently induced necrosis or apoptosis in gastric cancer cells via generation of reactive oxygen species
- (2014) Mu-Jang Lee et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells
- (2014) Dongzhu Duan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention
- (2014) Brendan Ffrench et al. Molecular Cancer
- Theranostic Properties of a Survivin-Directed Molecular Beacon in Human Melanoma Cells
- (2014) Sara Carpi et al. PLoS One
- Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
- (2012) Dimitrios Anastasiou et al. Nature Chemical Biology
- Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer
- (2012) Jae Yun Lim WORLD JOURNAL OF GASTROENTEROLOGY
- Selective killing of cancer cells by a small molecule targeting the stress response to ROS
- (2011) Lakshmi Raj et al. NATURE
- Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
- (2011) J Chen et al. ONCOGENE
- Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis
- (2009) Weidong Han et al. APOPTOSIS
- Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
- (2009) Pepita Gimenez-Bonafe et al. CURRENT CANCER DRUG TARGETS
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- An overview of cancer multidrug resistance: a still unsolved problem
- (2008) H. Lage CELLULAR AND MOLECULAR LIFE SCIENCES
- Shikonin exerts antitumor activityviaproteasome inhibition and cell death inductionin vitroandin vivo
- (2008) Huanjie Yang et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now